RSM logo
International Journal of STD & AIDS

Home Current issue Browse archive Alerts About the journal Feedback
 
Int J STD AIDS 2009;20:410-413
doi:10.1258/ijsa.2008.008353
© 2009 Royal Society of Medicine Press

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Agaba, P A
Right arrow Articles by Kanki, P
PubMed
Right arrow PubMed Citation
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Original research articles

Presentation and survival of patients with AIDS-related Kaposi's sarcoma in Jos, Nigeria

P A Agaba FWACP * , H M Sule FMCGP *, R O Ojoh FWACP *, Z Hassan BmBcH *, L Apena HND *, M A Mu'azu MSc *, B Badung MSc *, O O Agbaji FMCP *, J A Idoko FMCP * and P Kanki DSc {dagger}

* AIDS Prevention Initiative Nigeria (APIN) Centre, Jos University Teaching Hospital, Jos, Nigeria; {dagger} Harvard School of Public Health, Boston, MA, USA

Correspondence to: Patricia A Agaba, AIDS Prevention Initiative Nigeria Plus (APIN Plus), Jos University Teaching Hospital, P.M.B. 2076, Jos, Plateau State, Nigeria Email: ellagaba{at}yahoo.com

AIDS-related Kaposi's sarcoma (AIDS-KS) remains a significant cause of morbidity and mortality. We describe the pattern of presentation and survival in Jos, Nigeria. We identified 48 HIV-positive patients with AIDS-KS and matched them for age and sex with an equal number of HIV-positive patients without AIDS-KS. We compared their clinical, immunological, virological characteristics and survival. They were similar in age and body mass index profile but patients with AIDS-KS had more tuberculosis co-infection (P, 0.02), lower median CD4 count (P, 0.003) and higher mortality (P, 0.002). Surprisingly, patients with AIDS-KS had lower levels of median viral load (29,347 copies/mL) compared with controls (80,533 copies/mL). We recommend specific AIDS-KS therapy in addition to highly active antiretroviral therapy in order to improve survival.

Key Words: AIDS-related Kaposi's sarcoma • survival • Nigeria


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




History of the London Clinic